• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Percutaneous coronary intervention versus coronary artery bypass graft in chronic kidney disease: Optimal treatment options.

作者信息

Kar Subrata, Coats Walter, Aggarwal Kul

机构信息

Division of Cardiovascular Medicine, University of Missouri Hospital and Clinics, Columbia, Missouri, USA.

出版信息

Hemodial Int. 2011 Oct;15 Suppl 1:S30-6. doi: 10.1111/j.1542-4758.2011.00599.x.

DOI:10.1111/j.1542-4758.2011.00599.x
PMID:22093598
Abstract

Chronic kidney disease (CKD) is ubiquitous in the world and may eventually progress to end-stage renal disease. CKD is associated with a greater risk of coronary artery disease (CAD) which is the leading cause of mortality in this population. Current invasive treatment options include percutaneous coronary intervention or coronary artery bypass graft. We performed a PubMed search to ascertain the optimal treatment for coronary artery disease in CKD. Our review of the current literature supports the superiority of coronary artery bypass grafting which reduces repeat revascularizations, improves angina symptoms, and increases long-term survival.

摘要

相似文献

1
Percutaneous coronary intervention versus coronary artery bypass graft in chronic kidney disease: Optimal treatment options.
Hemodial Int. 2011 Oct;15 Suppl 1:S30-6. doi: 10.1111/j.1542-4758.2011.00599.x.
2
Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease.慢性肾脏病患者多支冠状动脉疾病行冠状动脉旁路移植术或药物洗脱支架植入术的短期和长期预后
Am J Cardiol. 2010 Aug 1;106(3):348-53. doi: 10.1016/j.amjcard.2010.03.037. Epub 2010 Jun 18.
3
Idiopathic thrombocytopenic purpura and coronary artery disease: comparison between coronary artery bypass grafting and percutaneous coronary intervention.特发性血小板减少性紫癜与冠状动脉疾病:冠状动脉旁路移植术与经皮冠状动脉介入治疗的比较
Interact Cardiovasc Thorac Surg. 2011 Aug;13(2):153-7. doi: 10.1510/icvts.2011.271296. Epub 2011 May 16.
4
Long-term comparison of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization: 5-year outcomes from the Asan Medical Center-Multivessel Revascularization Registry.多支血管冠状动脉血运重建中药物洗脱支架与冠状动脉旁路移植术的长期比较:来自 Asan 医疗中心多支血管血运重建登记处的 5 年结果。
J Am Coll Cardiol. 2011 Jan 11;57(2):128-37. doi: 10.1016/j.jacc.2010.09.022.
5
Percutaneous coronary intervention compared with coronary artery bypass graft in coronary artery disease patients with chronic kidney disease: a systematic review and meta-analysis.慢性肾脏病冠心病患者经皮冠状动脉介入治疗与冠状动脉旁路移植术的比较:一项系统评价和荟萃分析。
Ren Fail. 2014 Sep;36(8):1177-86. doi: 10.3109/0886022X.2014.934178. Epub 2014 Jul 2.
6
One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.冠状动脉旁路移植术与多系统疾病多支架经皮冠状动脉介入治疗的一年结局:来自随机临床试验个体患者数据的荟萃分析
J Thorac Cardiovasc Surg. 2005 Aug;130(2):512-9. doi: 10.1016/j.jtcvs.2004.12.049.
7
Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease.稳定性冠心病合并慢性肾脏病患者的最佳药物治疗联合或不联合经皮冠状动脉介入治疗。
Am J Cardiol. 2009 Dec 15;104(12):1647-53. doi: 10.1016/j.amjcard.2009.07.043.
8
Coronary revascularisation in chronic kidney disease. Part 1: stable coronary artery disease.
J Ren Care. 2010 May;36 Suppl 1:106-17. doi: 10.1111/j.1755-6686.2010.00156.x.
9
[Hybrid vascular intervention].[杂交血管介入治疗]
Nihon Rinsho. 2011 Feb;69(2):343-8.
10
Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS).慢性肾脏病与冠状动脉血运重建术后临床结局的关联:动脉血运重建治疗研究(ARTS)
Am Heart J. 2005 Mar;149(3):512-9. doi: 10.1016/j.ahj.2004.10.010.

引用本文的文献

1
Cardiac arrest during percutaneous coronary intervention in a patient 'resistant' to clopidogrel - successful 50-minute mechanical chest compression.对氯吡格雷“抵抗”的患者在经皮冠状动脉介入治疗期间发生心脏骤停——成功进行50分钟的机械胸外按压
Postepy Kardiol Interwencyjnej. 2013;9(4):394-6. doi: 10.5114/pwki.2013.38873. Epub 2013 Nov 18.